Pentagastrin enhances gastric mucosal defenses in vivo: luminal acid-dependent and independent effects
- PMID: 8048536
- DOI: 10.1152/ajpgi.1994.267.1.G94
Pentagastrin enhances gastric mucosal defenses in vivo: luminal acid-dependent and independent effects
Abstract
Stimulation of acid secretion is associated with enhanced resistance of the gastric mucosa to damage by luminal acid. We studied the mechanism by which gastric mucosal defenses are modulated in a system in which mucus gel thickness, intracellular pH (pHi), gastric mucosal blood flow, and acid secretion can be measured simultaneously in vivo, using a recently developed microfluorometric technique. Intravenous infusion of pentagastrin in a dose associated with maximal acid secretion increased mucus gel thickness, pHi, and mucosal blood flow during superfusion with a neutral solution. Subsequent superfusion with an acidic buffer (pH 1.7) further increased blood flow to nearly three times basal. During superfusion with luminal acid, pHi fell more slowly and recovered toward baseline more quickly in pentagastrin-infused rats than in controls. Pretreatment with the H2-receptor antagonist cimetidine abolished the increased blood flow associated with pentagastrin, impairing pHi homeostasis, although cimetidine increased mucus gel thickness in the absence of pentagastrin. We conclude that gastric defense mechanisms at the preendothelial and postepithelial levels are enhanced during acid secretion as part of a histamine-dependent homeostatic mechanism that balances gastric protective mechanisms with acid secretion. The net result of these enhanced defenses is the preservation of gastric surface cell pHi despite the presence of a large proton gradient between lumen and blood.
Similar articles
-
Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.Gut. 1998 Sep;43(3):334-41. doi: 10.1136/gut.43.3.334. Gut. 1998. PMID: 9863477 Free PMC article.
-
Indomethacin does not alter the effect of pentagastrin on rat gastric defense mechanisms.Peptides. 1996;17(1):155-9. doi: 10.1016/0196-9781(95)02056-x. Peptides. 1996. PMID: 8822525
-
Central vagal activation increases mucus gel thickness and surface cell intracellular pH in rat stomach.Gastroenterology. 1997 Feb;112(2):409-17. doi: 10.1053/gast.1997.v112.pm9024294. Gastroenterology. 1997. PMID: 9024294
-
Integrated duodenal protective response to acid.Life Sci. 2001 Nov 9;69(25-26):3073-81. doi: 10.1016/s0024-3205(01)01413-8. Life Sci. 2001. PMID: 11758832 Review.
-
How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses?Clin Invest Med. 1987 May;10(3):251-8. Clin Invest Med. 1987. PMID: 3304754 Review.
Cited by
-
Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.Gut. 1998 Sep;43(3):334-41. doi: 10.1136/gut.43.3.334. Gut. 1998. PMID: 9863477 Free PMC article.
-
New insights into impairment of mucosal defense in portal hypertensive gastric mucosa.J Gastrointest Surg. 2000 Sep-Oct;4(5):458-63. doi: 10.1016/s1091-255x(00)80086-4. J Gastrointest Surg. 2000. PMID: 11077319
-
Effect of gastric secretion on penetration of N-3H-methyl-N-nitro-N-nitrosoguanidine into gastric mucosa of rats.Dig Dis Sci. 1998 Sep;43(9):2012-20. doi: 10.1023/a:1018898928870. Dig Dis Sci. 1998. PMID: 9753267
-
Gastroprotective effect of ranitidine bismuth citrate is associated with increased mucus bismuth concentration in rats.Gut. 1996 Aug;39(2):164-71. doi: 10.1136/gut.39.2.164. Gut. 1996. PMID: 8977335 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources